Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2 (original) (raw)

Discovering small-molecule therapeutics against SARS-CoV-2

Vaibhav Tiwari

Drug Discovery Today, 2020

View PDFchevron_right

Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors

Niloofar Mohammadi

Informatics in Medicine Unlocked, 2020

View PDFchevron_right

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

Gaurav Joshi

Cellular Signalling, 2020

View PDFchevron_right

In Silico Study Of Natural Compound Candidates As Promising Drugs For SARS-Cov-2

abeer sharfalddin

International Journal of Scientific & Technology Research, 2021

View PDFchevron_right

Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets

ahmed abdullh mohamed

Chemical Papers, 2021

View PDFchevron_right

Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection

Rajiv Tonk

Reviews in Cardiovascular Medicine, 2020

View PDFchevron_right

Antiviral drug discovery: preparing for the next pandemic

Rosemary Dorrington

Chemical Society Reviews, 2021

View PDFchevron_right

In silico identification of approved drugs for potential prophylactic uses against SARS-CoV-2 infection

Ikemefuna Uzochukwu

Magna Scientia Advanced Biology and Pharmacy, 2024

View PDFchevron_right

COVID-19 and SARS-CoV-2: Despite the vaccination, new targets/drugs for treatment and the virus cycle mechanisms still have to be continually investigated

Marcia Rodrigues Amorim

Open Journal of Proteomics and Genomics, 2021

View PDFchevron_right

OVERVIEW OF ANTIVIRAL DRUGS AGAINST SARS-CoV-2 FOR THE TREATMENT OF COVID-19

Marko Anderluh

Acta Medica Medianae, 2021

View PDFchevron_right

The broad-spectrum antiviral recommendations for drug discovery against COVID-19

Huma Naeem

Drug Metabolism Reviews, 2020

View PDFchevron_right

Computational design for the development of natural molecules as compelling inhibitors against the target SARS-CoV-2: An in-silico attempt

Nagarjuna Palathoti

journal of applied pharmaceutical science, 2022

View PDFchevron_right

Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19

Dibyajyoti Banerjee

European Journal of Pharmacology, 2021

View PDFchevron_right

Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19

karamjeet kaur

Naunyn-Schmiedeberg's Archives of Pharmacology, 2021

View PDFchevron_right

In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals

yusuf şimşek

Journal of Molecular Graphics and Modelling, 2021

View PDFchevron_right

Current trends and possible therapeutic options against COVID-19

Uzair Ahmed

Journal of Microbiology and Infectious Diseases, 2020

View PDFchevron_right

Editorial: Biomolecules Against Coronaviruses: Molecular Aspects, Multi-Omics and Systems Pharmacology

Ilaria Peluso

Frontiers in Pharmacology, 2022

View PDFchevron_right

In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)

Jahan B. Ghasemi

Informatics in Medicine Unlocked

View PDFchevron_right

Drug repurposing for SARS-COV-2: A molecular docking, molecular dynamics, machine learning, and ab initio study

Jatin Kashyap

2021

View PDFchevron_right

Emerging Therapeutic Options for COVID-19

sheetal khubchandani

Journal of Evolution of Medical and Dental Sciences, 2020

View PDFchevron_right

Computational Determination of Potential Inhibitors of SARS-CoV2 Main Protease

Ly Le

View PDFchevron_right

A new way to fight sars-cov-19

Valentyn Nastasenko

Materials Science and Nanotechnology, 2021

View PDFchevron_right

Drugs for COVID-19 Treatment: A New Challenge

Arunima Saha

Applied Biochemistry and Biotechnology

View PDFchevron_right

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Elena Moreno

Nature, 2020

View PDFchevron_right

SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines

Laura Bonifaz

Boletín Médico del Hospital Infantil de México

View PDFchevron_right

Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes

Ş.Güniz Küçükgüzel

Journal of research in pharmacy, 2021

View PDFchevron_right

CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2

vandna sapehia

Frontiers in Microbiology, 2020

View PDFchevron_right

High throughput screening identifies broad-spectrum Coronavirus entry inhibitors

Fabrice Agou

bioRxiv (Cold Spring Harbor Laboratory), 2023

View PDFchevron_right

Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms

Mark Harold Paz Mendoza

Journal of Biomolecular Structure and Dynamics, 2020

View PDFchevron_right

Evolving pharmaceutical therapies for confronting COVID-19: An overview

Nagarajan Kandasamy

AIP Conference Proceedings

View PDFchevron_right

Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus

Amgad Rabie

2023

View PDFchevron_right

Race to arsenal COVID-19 therapeutics: Current alarming status and future directions

Ankit Kumar Dubey

Chemico-Biological Interactions, 2020

View PDFchevron_right

Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic

vikramdeep monga

Acta Scientific Pharmaceutical Sciences, 2021

View PDFchevron_right

Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial

Mojtaba Mousavi

Drug Metabolism Reviews, 2020

View PDFchevron_right

Updates on the Current Antivirals Therapy for the COVID-19 Pandemic: A Mini-Review

Aymen Elsous

American Journal of Laboratory Medicine, 2020

View PDFchevron_right